The global metagenomics market accounted for USD 1.55 billion in 2023 and is expected to reach at USD 7.09 billion by 2034 with a CAGR of 14.83% during the forecast period 2024-2034. Rise in both international & national genome projects, increasing prevalence of infectious diseases, surge in research & development activities, establishment of biotech startups, growing technological advancements, rising investments from major market players, international players are initiating domestic manufacturing facilities to streamline supply & distribution, and increasing introduction of innovative metagenomics platforms are some of the key factors boosting the market growth.
Metagenomics represents an innovative branch of genomics dedicated to examining the genetic material derived from intricate microbial communities, encompassing bacteria, viruses, fungi, and other microorganisms. In contrast to conventional genomics, which concentrates on single organisms, metagenomics seeks to comprehend the combined genetic composition of complete ecosystems. Furthermore, metagenomic research has provided access to a vast array of microbial diversity previously overlooked by conventional microbiological methods. Hence, increasing introduction of innovative metagenomics platforms is predicted to boost the market growth during the forecast period. For instance, in March 2023, Illumina Inc., a prominent company in DNA sequencing and array-based technologies worldwide, has introduced Connected Insights, a novel cloud-based software designed to facilitate tertiary analysis for clinical next-generation sequencing (NGS) data.
By product, kits & reagents was the highest revenue-grossing segment in the global metagenomics market in 2023 owing to a various reagents are used in sequencing to prepare the sample experimentally and surge in launch of new products. Additionally, sequencing & data analytics services is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of sequencing, increased need for data analysis platforms, growing introduction of more advanced platforms. For instance, in March 2022, Thermo Fisher Scientific has introduced the Ion Torrent Genexus Dx Integrated Sequencer, an automated platform for next-generation sequencing (NGS).
By technology, shotgun sequencing was the highest revenue-grossing segment in the global metagenomics market in 2023 owing to the surge in number of academic institutions & research centers are embracing technology for their genetic studies and ongoing technological advancements. Additionally, whole genome sequencing is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on expansion by companies in the clinical rare disease diagnosis space and rising launch of novel platforms. For instance, in September 2022, Illumina Inc introduced the NovaSeq X series production-scale sequencers, capable of producing over 20,000 whole genomes annually, marking a throughput increase of 2.5 times compared to previous Illumina sequencers.
By workflow, sequencing was the highest revenue-grossing segment in the global metagenomics market in 2023 owing to the cost-effectiveness & more accuracy, growing technological advancement in sequencing, surge in genetic research, increasing funding by major market players, and rising launch of novel workflow. For instance, in November 2023, QIAGEN introduced Microbiome WGS SeqSets, a complete workflow from sample to insight tailored for microbiome research, aiming to offer a user-friendly solution that optimizes efficiency and reproducibility. Additionally, pre-sequencing is predicted to grow at the fastest CAGR during the forecast period owing to the availability of technologically advanced sample processing & library preparation assay kits and increase in the number of research projects focusing on metagenome sequencing.
By application, environmental was the highest revenue-grossing segment in the global metagenomics market in 2023. Metagenomics research is quickly expanding its role in agriculture and environmental conservation. It involves the use of sequencing analysis or gene screening to comprehend microorganisms obtained from specific environments. Additionally, clinical diagnostics is predicted to grow at the fastest CAGR during the forecast period owing to the rise in infectious diseases, growing adoption of metagenomics in clinical labs, and increase in the introduction of advanced metagenomics platforms. For instance, in October 2022, SYNLAB and Microba Life Sciences (Microba) have extended their strategic partnership to enhance the distribution of the microbiome test myBIOME across Europe and Latin America, expanding its geographic and market reach.
North America region is anticipated for the highest revenue share during the forecast period owing to the presence of key companies, rise in R&D funding, advancements in sequencing technology, growing collaboration between companies & academic institutions, and increased initiatives by market players. For instance, in April 2023, Pattern Ag has unveiled the largest metagenomics-based ecosystem database, with a focus on developing a global soil microbiome map to support agricultural genomics research. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing use of metagenomics across various applications, heightened emphasis on genomics & proteomics research, surge in investment from major market players. For instance, in October 2023, Leucine Rich Bio, an Indian microbiome company, secured an undisclosed sum in a pre-Series A funding round. The company plans to allocate the funds towards the development and marketing of new products.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Metagenomics represents an innovative branch of genomics dedicated to examining the genetic material derived from intricate microbial communities, encompassing bacteria, viruses, fungi, and other microorganisms. In contrast to conventional genomics, which concentrates on single organisms, metagenomics seeks to comprehend the combined genetic composition of complete ecosystems. Furthermore, metagenomic research has provided access to a vast array of microbial diversity previously overlooked by conventional microbiological methods. Hence, increasing introduction of innovative metagenomics platforms is predicted to boost the market growth during the forecast period. For instance, in March 2023, Illumina Inc., a prominent company in DNA sequencing and array-based technologies worldwide, has introduced Connected Insights, a novel cloud-based software designed to facilitate tertiary analysis for clinical next-generation sequencing (NGS) data.
By product, kits & reagents was the highest revenue-grossing segment in the global metagenomics market in 2023 owing to a various reagents are used in sequencing to prepare the sample experimentally and surge in launch of new products. Additionally, sequencing & data analytics services is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of sequencing, increased need for data analysis platforms, growing introduction of more advanced platforms. For instance, in March 2022, Thermo Fisher Scientific has introduced the Ion Torrent Genexus Dx Integrated Sequencer, an automated platform for next-generation sequencing (NGS).
By technology, shotgun sequencing was the highest revenue-grossing segment in the global metagenomics market in 2023 owing to the surge in number of academic institutions & research centers are embracing technology for their genetic studies and ongoing technological advancements. Additionally, whole genome sequencing is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on expansion by companies in the clinical rare disease diagnosis space and rising launch of novel platforms. For instance, in September 2022, Illumina Inc introduced the NovaSeq X series production-scale sequencers, capable of producing over 20,000 whole genomes annually, marking a throughput increase of 2.5 times compared to previous Illumina sequencers.
By workflow, sequencing was the highest revenue-grossing segment in the global metagenomics market in 2023 owing to the cost-effectiveness & more accuracy, growing technological advancement in sequencing, surge in genetic research, increasing funding by major market players, and rising launch of novel workflow. For instance, in November 2023, QIAGEN introduced Microbiome WGS SeqSets, a complete workflow from sample to insight tailored for microbiome research, aiming to offer a user-friendly solution that optimizes efficiency and reproducibility. Additionally, pre-sequencing is predicted to grow at the fastest CAGR during the forecast period owing to the availability of technologically advanced sample processing & library preparation assay kits and increase in the number of research projects focusing on metagenome sequencing.
By application, environmental was the highest revenue-grossing segment in the global metagenomics market in 2023. Metagenomics research is quickly expanding its role in agriculture and environmental conservation. It involves the use of sequencing analysis or gene screening to comprehend microorganisms obtained from specific environments. Additionally, clinical diagnostics is predicted to grow at the fastest CAGR during the forecast period owing to the rise in infectious diseases, growing adoption of metagenomics in clinical labs, and increase in the introduction of advanced metagenomics platforms. For instance, in October 2022, SYNLAB and Microba Life Sciences (Microba) have extended their strategic partnership to enhance the distribution of the microbiome test myBIOME across Europe and Latin America, expanding its geographic and market reach.
North America region is anticipated for the highest revenue share during the forecast period owing to the presence of key companies, rise in R&D funding, advancements in sequencing technology, growing collaboration between companies & academic institutions, and increased initiatives by market players. For instance, in April 2023, Pattern Ag has unveiled the largest metagenomics-based ecosystem database, with a focus on developing a global soil microbiome map to support agricultural genomics research. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing use of metagenomics across various applications, heightened emphasis on genomics & proteomics research, surge in investment from major market players. For instance, in October 2023, Leucine Rich Bio, an Indian microbiome company, secured an undisclosed sum in a pre-Series A funding round. The company plans to allocate the funds towards the development and marketing of new products.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Technology, Workflow, and Application
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Metagenomics Market Report 2023 - 2034
Metagenomics Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Sequencing & Data Analytics Services
- Kits & Reagents
- Software
Metagenomics Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Whole Genome Sequencing
- Shotgun Sequencing
- 16S Sequencing
- Others
Metagenomics Market Analysis & Forecast by Workflow 2023 - 2034 (Revenue USD Bn)
- Pre-sequencing
- Data Analysis
- Sequencing
Metagenomics Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Clinical Diagnostics
- Food & Nutrition
- Drug Discovery
- Environmental
- Biotechnology
- Others
Metagenomics Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Metagenomics Market: Product Estimates & Trend Analysis
8. Metagenomics Market: Technology Estimates & Trend Analysis
9. Metagenomics Market: Workflow Estimates & Trend Analysis
10. Metagenomics Market: Application Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Metagenomics Market
13. Europe Global Metagenomics Market
14. Asia Pacific Global Metagenomics Market
15. Latin America Global Metagenomics Market
16. MEA Global Metagenomics Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Promega Corporation
- PerkinElmer Inc.
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- Novogene Co. Ltd.
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories
- Oxford Nanopore Technologies
